Completed
A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer
NCT02149524
- Conditions
- HER2 Positive Early or Locally Advanced Breast Cancer
- Locations
-
- Investigational Site Prague, Czechia